Modeling neuropsychiatric disorders using human induced pluripotent stem cells
- PMID: 31134525
- PMCID: PMC6949328
- DOI: 10.1007/s13238-019-0638-8
Modeling neuropsychiatric disorders using human induced pluripotent stem cells
Abstract
Neuropsychiatric disorders are complex disorders characterized by heterogeneous genetic variations, variable symptoms, and widespread changes in anatomical pathology. In the context of neuropsychiatric disorders, limited access to relevant tissue types presents challenges for understanding disease etiology and developing effective treatments. Induced pluripotent stem cells (iPSCs) reprogrammed from patient somatic cells offer an opportunity to recapitulate disease development in relevant cell types, and they provide novel approaches for understanding disease mechanisms and for development of effective treatments. Here we review recent progress and challenges in differentiation paradigms for generating disease-relevant cells and recent studies of neuropsychiatric disorders using human pluripotent stem cell (hPSC) models where cellular phenotypes linked to disease have been reported. The use of iPSC-based disease models holds great promise for understanding disease mechanisms and supporting discovery of effective treatments.
Keywords: autism spectrum disorder; bipolar disorder; brain organoid; iPSCs; neuropsychiatric disorders; schizophrenia.
Similar articles
-
Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.Mol Cell Neurosci. 2016 Jun;73:104-15. doi: 10.1016/j.mcn.2016.01.011. Epub 2016 Jan 28. Mol Cell Neurosci. 2016. PMID: 26826498 Free PMC article. Review.
-
Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells.Adv Exp Med Biol. 2019;1192:297-312. doi: 10.1007/978-981-32-9721-0_15. Adv Exp Med Biol. 2019. PMID: 31705501
-
Reaching into the toolbox: Stem cell models to study neuropsychiatric disorders.Stem Cell Reports. 2022 Feb 8;17(2):187-210. doi: 10.1016/j.stemcr.2021.12.015. Epub 2022 Jan 20. Stem Cell Reports. 2022. PMID: 35063127 Free PMC article. Review.
-
Modeling psychiatric disorders with patient-derived iPSCs.Curr Opin Neurobiol. 2016 Feb;36:118-27. doi: 10.1016/j.conb.2015.11.003. Epub 2015 Dec 17. Curr Opin Neurobiol. 2016. PMID: 26705693 Free PMC article. Review.
-
In vitro models for ASD-patient-derived iPSCs and cerebral organoids.Prog Mol Biol Transl Sci. 2020;173:355-375. doi: 10.1016/bs.pmbts.2020.04.019. Epub 2020 May 27. Prog Mol Biol Transl Sci. 2020. PMID: 32711817 Review.
Cited by
-
Morphological and transcriptomic analyses of stem cell-derived cortical neurons reveal mechanisms underlying synaptic dysfunction in schizophrenia.Genome Med. 2023 Jul 28;15(1):58. doi: 10.1186/s13073-023-01203-5. Genome Med. 2023. PMID: 37507766 Free PMC article.
-
Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine's fast-acting antidepressant mechanisms.Ther Adv Psychopharmacol. 2020 Nov 2;10:2045125320968331. doi: 10.1177/2045125320968331. eCollection 2020. Ther Adv Psychopharmacol. 2020. PMID: 33224469 Free PMC article. Review.
-
Translating insights from neuropsychiatric genetics and genomics for precision psychiatry.Genome Med. 2020 Apr 29;12(1):43. doi: 10.1186/s13073-020-00734-5. Genome Med. 2020. PMID: 32349784 Free PMC article. Review.
-
Advances in development and application of human organoids.3 Biotech. 2021 Jun;11(6):257. doi: 10.1007/s13205-021-02815-7. Epub 2021 May 8. 3 Biotech. 2021. PMID: 33977021 Free PMC article. Review.
-
'Channeling' therapeutic discovery for epileptic encephalopathy through iPSC technologies.Trends Pharmacol Sci. 2022 May;43(5):392-405. doi: 10.1016/j.tips.2022.03.001. Trends Pharmacol Sci. 2022. PMID: 35427475 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical